Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management
Caroline E. Dale et al.
NATURE MEDICINE (2023)
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
Zahra Raisi-Estabragh et al.
HEART (2023)
Network expansion of genetic associations defines a pleiotropy map of human cell biology
Inigo Barrio-Hernandez et al.
NATURE GENETICS (2023)
Proteogenomic links to human metabolic diseases
Mine Koprulu et al.
NATURE METABOLISM (2023)
Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Obesity and risk of female reproductive conditions: A Mendelian randomisation study
Samvida S. Venkatesh et al.
PLOS MEDICINE (2022)
Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
Iris Szu-Szu Ho et al.
BMJ OPEN (2022)
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease
Kiran J. Biddinger et al.
JAMA NETWORK OPEN (2022)
Rare and common genetic determinants of metabolic individuality and their effects on human health
Praveen Surendran et al.
NATURE MEDICINE (2022)
The burden and risks of emerging complications of diabetes mellitus
Dunya Tomic et al.
NATURE REVIEWS ENDOCRINOLOGY (2022)
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
Maik Pietzner et al.
NATURE COMMUNICATIONS (2022)
Multimorbidity
Soren T. Skou et al.
NATURE REVIEWS DISEASE PRIMERS (2022)
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
Johan H. Thygesen et al.
LANCET DIGITAL HEALTH (2022)
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Kjetil Bjornevik et al.
SCIENCE (2022)
A cross-platform approach identifies genetic regulators of human metabolism and health
Luca A. Lotta et al.
NATURE GENETICS (2021)
Large-scale integration of the plasma proteome with genetics and disease
Egil Ferkingstad et al.
NATURE GENETICS (2021)
Plasma metabolites to profile pathways in noncommunicable disease multimorbidity
Maik Pietzner et al.
NATURE MEDICINE (2021)
Mapping the proteo-genomic convergence of human diseases
Maik Pietzner et al.
SCIENCE (2021)
A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits
Christopher N. Foley et al.
NATURE COMMUNICATIONS (2021)
Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies
Iris Szu-Szu Ho et al.
LANCET PUBLIC HEALTH (2021)
Exploiting the GTEx resources to decipher the mechanisms at GWAS loci
Alvaro N. Barbeira et al.
GENOME BIOLOGY (2021)
The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer
Hermann Gram
PHARMACOLOGICAL RESEARCH (2020)
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients
Marco Proietti et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study
Mika Kivimaki et al.
LANCET PUBLIC HEALTH (2020)
Rising to the challenge of multimorbidity
Christopher J. M. Whitty et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Map clusters of diseases to tackle multimorbidity
Christopher J. M. Whitty et al.
NATURE (2020)
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martin R. Cowie et al.
NATURE REVIEWS CARDIOLOGY (2020)
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie Zheng et al.
NATURE GENETICS (2020)
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
Jonas Bovijn et al.
LANCET RHEUMATOLOGY (2020)
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Lasse Folkersen et al.
NATURE METABOLISM (2020)
Genetic correlations of polygenic disease traits: from theory to practice
Wouter van Rheenen et al.
NATURE REVIEWS GENETICS (2019)
Improving the odds of drug development success through human genomics: modelling study
Aroon D. Hingorani et al.
SCIENTIFIC REPORTS (2019)
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
Emily A. King et al.
PLOS GENETICS (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model
Andrew Kingston et al.
AGE AND AGEING (2018)
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis
Constantinos A. Parisinos et al.
GASTROENTEROLOGY (2018)
Melioidosis
W. Joost Wiersinga et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus A Mendelian Randomization Analysis
Caroline E. Dale et al.
CIRCULATION (2017)
GUIDELINES Clinical assessment and management of multimorbidity: summary of NICE guidance
Caroline Farmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
GUIDELINES Clinical assessment and management of multimorbidity: summary of NICE guidance
Caroline Farmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment
Flora E. van Leeuwen et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
Michael V. Holmes et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
Interleukin-6 receptor pathways in abdominal aortic aneurysm
Seamus C. Harrison et al.
EUROPEAN HEART JOURNAL (2013)
Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
Ricardo C. Ferreira et al.
PLOS GENETICS (2013)
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
Karen Barnett et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)